Notably, the use of the mitochondrial antioxidant Mito-Tempo (MT) (Fig. 4H) alleviated the reduction in tight junction protein expression in CRS mice (Fig. 4I, J) and reversed the expression of p-MLC2 and MLCK in CRS (Fig. 4K). The gene discussed is MYL2; the disease is congenital rubella syndrome.